BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells

Oncogene

Volumn 23, Issue 58, 2004, Pages 9326-9335

  Miyazaki, Hideyo ^a,b   Watabe, Tetsuro ^a   Kitamura, Tadaichi ^a   Miyazono, Kohei ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

DU 145; p21CIP1 WAF1; PC 3; pRb

Indexed keywords

ACTIVIN RECEPTOR; ACTIVIN RECEPTOR LIKE KINASE 6; ANDROGEN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BOVINE SERUM ALBUMIN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; DOXYCYCLINE; OSTEOGENIC PROTEIN 1; RETINOBLASTOMA PROTEIN; TETRACYCLINE; THYMIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CDK1 GENE; CELL COUNT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; FLOW CYTOMETRY; GENE; GENE INDUCTION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE TUMOR; PROTEIN DEPHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION;

ANDROGENS; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEINS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; IMMUNOPRECIPITATION; MALE; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GROWTH FACTOR; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

ANIMALIA; BOVINAE; MUS MUSCULUS;

EID: 11244256523     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208127     Document Type: Article

References (39)

1. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE and Hamdy FC. (1998). Br. J. Cancer, 78, 1219-1223.
2. Baron U, Gossen M and Bujard H. (1997). Nucleic Acids Res., 25, 2723-2729.
3. Brubaker KD, Corey E, Brown LG and Vessella RL. (2004). J. Cell. Biochem., 91, 151-160.
4. Buchkovich K, Duffy LA and Harlow E. (1989). Cell, 58, 1097-1105.
5. Callahan JF, Burgess JL, Fornwald JA, Gaster LM, Harling JD, Harrington FP, Heer J, Kwon C, Lehr R, Mathur A, Olson BA, Weinstock J and Laping NJ. (2002). J. Med. Chem., 45, 999-1001.
6. Candia AF, Watabe T, Hawley SH, Onichtchouk D, Zhang Y, Derynck R, Niehrs C and Cho KW. (1997). Development, 124, 4467-4480.
7. Clarke NW, McClure J and George NJ. (1991). Br. J. Urol., 68, 74-80.
8. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K and Imamura T. (1999). J. Cell Sci., 112, 3519-3527.
9. Era T and Witte ON. (2000). Proc. Natl. Acad. Sci. USA, 97, 1737-1742.
10. Franzen A and Heldin NE. (2001). Biochem. Biophys. Res. Commun., 285, 773-781.
11. Ghosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL and Kreisberg J. (2000a). Biochim. Biophys. Acta, 1497, 186-196.
12. Ghosh-Choudhury N, Woodruff K, Qi W, Celeste A, Abboud SL and Ghosh-Choudhury G. (2000b). Biochem. Biophys. Res. Commun., 272, 705-711.
13. Greenlee RT, Hill-Harmon MB, Murray T and Thun M. (2001). Cancer J. Clin., 51, 15-36.
14. Guo Y and Kyprianou N. (1998). Cell Growth Differ., 9, 185-193.
15. Hogan BL. (1996). Genes Dev., 10, 1580-1594.
16. Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T and Terada M. (1997). Cancer Res., 57, 5022-5027.
17. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ and Hill CS. (2002). Mol. Pharmacol., 62, 65-74.
18. Ishikawa T, Yoshioka H, Ohuchi H, Noji S and Nohno T. (1995). Biochem. Biophys. Res. Commun., 216, 26-33.
19. Kawabata M, Imamura T and Miyazono K. (1998a). Cytokine Growth Factor Rev., 9, 49-61.
20. Kawabata M, Inoue H, Hanyu A, Imamura T and Miyazono K. (1998b). EMBO J., 17, 4056-4065.
21. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M and Lee C. (1996). Cancer Res., 56, 44-48.
22. Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK and Morton RA. (2000). Cancer Res., 60, 2840-2844.
23. Li CY, Suardet L and Little JB. (1995). J. Biol. Chem., 270, 4971-4974.
24. Liu F, Ventura F, Doody J and Massague J. (1995). Mol. Cell. Biol., 15, 3479-3486.
25. Massague J. (1998). Annu. Rev. Biochem., 67, 753-791.
26. Massague J, Blain SW and Lo RS. (2000). Cell, 103, 295-309.
27. Masuda H, Fukabori Y, Nakano K, Takezawa Y, Suzuki T and Yamanaka H. (2003). Prostate, 54, 268-274.
28. Miyazono K. (2000). J. Cell Sci., 113, 1101-1109.
29. Niwa H, Yamamura K and Miyazaki J. (1991). Genes, 8, 193-199.
30. Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H and Miyazono K. (2002). J. Cell. Physiol., 193, 299-318.
31. Park BJ, Park JI, Byun DS, Park JH and Chi SG. (2000). Cancer Res., 60, 3031-3038.
32. Reddi AH. (1998). Nat. Biotechnol., 16, 247-252.
33. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH and Miyazono K. (1995). Proc. Natl. Acad. Sci. USA, 92, 7632-7636.
34. Scher HI and Yagoda A. (1987). Am. J. Med., 82, 6-28.
35. Thomas R, Anderson WA, Raman V and Reddi AH. (1998). Prostate, 37, 236-245.
36. Vindelov LL, Christensen IJ and Nissen NI. (1983). Cytometry, 3, 328-331.
37. Weinberg RA. (1995). Cell, 81, 323-330.
38. Wong GA, Tang V, El-Sabeawy F and Weiss RH. (2003). Am. J. Physiol. Endocrinol. Metab., 284, E972-E979.
39. Wozney JM and Rosen V. (1998). Clin. Orthop., 346, 26-37.